Yanyan Zheng

Yanyan Zheng

Company: Merck

Job title: Principal Scientist, Discovery Oncology


Yanyan Zheng is a Principal Scientist in Discovery Oncology at Merck & Co. Inc., leading the tumor intrinsic targeting and translational pathology group. As a seasoned drug hunter, she is interested in bringing innovative therapeutics to patients with unmet medical need.  Her expertise encompasses a broad range of processes in drug development, from target identification/validation, biologics discovery, to translational research. Dr. Zheng received her Ph.D. in Molecular Microbiology and Immunology, with a concurrent M.S.  degree in Biostatistics, from University of Southern California. She conducted her Postdoctoral Fellowship training in Cancer Biology at Stanford University.”


Testing Tumor-associated Macrophage Repolarization to Induce an Immune Response using Human Ex Vivo Tumor Cultures 1:00 pm - 4:00 pm

Join this workshop to: • Understand motivation for developing ex vivo cultures to test macrophage-based therapies against human cancers • Compare the advantages and disadvantages between tumor slice and tumor dissociated cultures • Review Keytruda and macrophage-repolarizing agents’ response across multiple tumor types • Leave understanding the implications of using human ex vivo tumor cultures…Read more

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.